doi: 10.1111/j.1423-0410.1977.tb00648.x.
Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin
- PMID: 67714
- DOI: 10.1111/j.1423-0410.1977.tb00648.x
Item in Clipboard
Development of an intravenous gamma-globulin with Fc activities. II. Reconversion of S-sulfonated human gamma-globulin into the original gamma-globulin
Vox Sang.
1977.
Abstract
The reconversion of S-sulfonated antitetanus gamma-globulin (S-GG) into the original gamma-globulin was studied. S-sulfonate groups in S-GG could be converted into disulfide bonds in vitro. The conversion restored the greater part of both complement-fixing and skin-sensitizing activities. S-GG administered intravenously formed interchain disulfide bonds again in vivo, which was accompanied by restoration of the C-dependent passive hemolytic activity. Intravenous injection of S-GG did not cause a significant decrease in serum complement level.
Similar articles
-
Development of an intravenous gamma-globulin with Fc activities. I. Preparation and characterization of S-sulfonated human gamma-globulin.Vox Sang. 1977;32(3):175-81. doi: 10.1111/j.1423-0410.1977.tb00622.x. Vox Sang. 1977. PMID: 67713
-
THE ROLE OF DISULFIDE BONDS IN THE COMPLEMENT-FIXING AND PRECIPITATING PROPERTIES OF 7S RABBIT AND SHEEP ANTIBODIES.J Exp Med. 1964 Oct 1;120(4):531-45. doi: 10.1084/jem.120.4.531. J Exp Med. 1964. PMID: 14212117 Free PMC article.
-
MOLECULAR BASIS OF PASSIVE SENSITIZATION. II. THE ROLE OF FRAGMENT 3 OF GAMMA-GLOBULIN AND ITS DISULFIDE BONDS IN PASSIVE SENSITIZATION AND COMPLEMENT FIXATION.J Immunol. 1964 Jul;93:59-68. J Immunol. 1964. PMID: 14214390 No abstract available.
-
[Adequate dosage of tetanus antitoxin and tetanus-immune human gamma globulin TIG in the treatment of tetanus].Masui. 1974 May;23(5):381-7. Masui. 1974. PMID: 4137369 Review. Japanese. No abstract available.
-
Thrombotic thrombocytopenic purpura: report of a case with a possible response to high-dose intravenous gamma globulin.Acta Haematol. 1989;82(4):201-4. doi: 10.1159/000205377. Acta Haematol. 1989. PMID: 2480050 Review.
Cited by
-
Prophylactic treatment with sulphonated immunoglobulin G attenuates development of mechanical allodynia-like response in mice with neuropathic pain.J Vet Med Sci. 2016 Jan;78(1):77-82. doi: 10.1292/jvms.15-0195. Epub 2015 Aug 29. J Vet Med Sci. 2016. PMID: 26321444 Free PMC article.
-
[Therapeutic use of immunoglobulins in children (author's transl)].Blut. 1980 Mar;40(3):215-24. doi: 10.1007/BF01008579. Blut. 1980. PMID: 6988023 Review. German.
-
Clinical trial of sulfonated immunoglobulin preparation for intravenous administration. I. Replacement therapy for primary immunodeficiency syndromes.Eur J Pediatr. 1981 May;136(2):159-65. doi: 10.1007/BF00441918. Eur J Pediatr. 1981. PMID: 6164554 Clinical Trial.
-
Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits.Infect Immun. 1987 Mar;55(3):547-54. doi: 10.1128/iai.55.3.547-554.1987. Infect Immun. 1987. PMID: 3493219 Free PMC article.
-
Evaluation of immunoglobulin G preparations for anti-cytomegalovirus antibodies with reference to neutralizing antibody in the presence of complement.J Clin Microbiol. 1988 Sep;26(9):1881-3. doi: 10.1128/jcm.26.9.1881-1883.1988. J Clin Microbiol. 1988. PMID: 2846652 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
